Generalized Anxiety Disorder
📧 Sign up to get email alerts when something new happens for Generalized Anxiety Disorder.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS trial_result · 2015-10-12Clinical Trial Update: Study of Pexacerfont (BMS-562086) in the Treatment of Outpatients With Generalized Anxiety Disorder [Phase 2, Phase 3]
Clinical trial update reporting a completed Phase 2/Phase 3 study of pexacerfont (BMS-562086) in outpatients with generalized anxiety disord…
-
FDA approval · 2015-09-18FDA Approved: BUSPIRONE HYDROCHLORIDE — Original Application (Heritage Pharmaceuticals Inc. d/b/a Avet Pharmaceuticals Inc.)
FDA approved an original ANDA for buspirone hydrochloride from Heritage Pharmaceuticals, enabling a generic version of buspirone hydrochlori…
-
FDA approval · 2015-09-09FDA Approved: ESCITALOPRAM OXALATE — Supplemental Application (Macleods Pharmaceuticals Limited)
FDA approved a supplemental application for escitalopram oxalate by Macleods Pharmaceuticals Limited.
-
FDA approval · 2015-08-28FDA Approved: ESCITALOPRAM — Original Application (SOLCO HEALTHCARE US, LLC)
The FDA approved an original application for a generic escitalopram product from Solco Healthcare US, LLC, for the treatment of major depres…
-
FDA approval · 2015-08-26FDA Approved: DULOXETINE — Original Application (Ascend Laboratories, LLC)
The FDA approved Ascend Laboratories' original application for a generic duloxetine product (ANDA 203197), establishing a generic version of…
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS trial_result · 2015-08-21Clinical Trial Update: Generalized Anxiety Disorder Proof of Concept Efficacy and Safety Study of SEP-225441 (Eszopiclone) In GAD Subjects [Phase 2]
A Phase 2 proof-of-concept efficacy and safety study of eszopiclone (SEP-225441) for Generalized Anxiety Disorder has completed, with result…
-
FDA approval · 2015-07-31FDA Approved: ALPRAZOLAM — Original Application (Aurobindo Pharma Limited)
The FDA approves Aurobindo Pharma Limited's generic alprazolam through an original ANDA submission, authorizing market entry of the generic …
-
CLINICAL_TRIALS trial_result · 2015-07-23Clinical Trial Update: Cognitive Behavior Treatment of Older Adults With Generalized Anxiety Disorder in Primary Care [NA]
This completed clinical trial evaluated cognitive behavioral therapy for generalized anxiety disorder in older adults in a primary care sett…
-
FDA approval · 2015-06-30FDA Approved: BUSPIRONE HYDROCHLORIDE — Supplemental Application (Strides Pharma Inc.)
The FDA approved Strides Pharma Inc.'s supplemental application for buspirone hydrochloride (generic), expanding approval of a generic buspi…
-
FDA approval · 2015-06-25FDA Approved: ESCITALOPRAM — Supplemental Application (Lupin Pharmaceuticals, Inc.)
FDA approved Lupin Pharmaceuticals' supplemental application for escitalopram (generic) under an ANDA, confirming the availability of a gene…
-
CLINICAL_TRIALS trial_result · 2015-06-23Clinical Trial Update: Relapse-prevention Study With Lu AA21004 (Vortioxetine) in Patients With Generalized Anxiety Disorder [Phase 3]
Phase 3 relapse-prevention study of vortioxetine (Lu AA21004) in generalized anxiety disorder has completed.
-
FDA approval · 2015-05-28FDA Approved: VENLAFAXINE HYDROCHLORIDE — Original Application (Yaopharma Co., Ltd.)
FDA approved Yaopharma Co., Ltd.'s original application for venlafaxine hydrochloride, authorizing a new generic version of the antidepressa…
-
CLINICAL_TRIALS trial_result · 2015-05-27Clinical Trial Update: Brain Markers of Anxiety Disorders and SSRI/CBT Treatment in Children and Adolescents
A completed clinical trial examined brain markers in youth with anxiety disorders and the effects of SSRI treatment and cognitive-behavioral…
-
FDA approval · 2015-05-14FDA Approved: ESCITALOPRAM OXALATE — Supplemental Application (Amneal Pharmaceuticals LLC)
FDA approved a supplemental application for escitalopram oxalate from Amneal Pharmaceuticals LLC, indicating approval of a supplemental gene…
-
CLINICAL_TRIALS trial_result · 2015-05-12Clinical Trial Update: Randomized, Placebo-Controlled Study: Effects of Lavender Aromatherapy on Preoperative Anxiety in Breast Patients [NA]
Randomized, placebo-controlled study evaluated whether lavender aromatherapy reduces preoperative anxiety in women undergoing breast surgery…
-
FDA approval · 2015-05-01FDA Approved: VENLAFAXINE — Supplemental Application (Heritage Pharmaceuticals Inc. d/b/a Avet Pharmaceuticals Inc.)
FDA approved a supplemental application for Venlafaxine from Heritage Pharmaceuticals Inc. d/b/a Avet Pharmaceuticals Inc. under an ANDA.
-
FDA approval · 2015-04-29FDA Approved: BUSPIRONE HYDROCHLORIDE — Supplemental Application (Teva Pharmaceuticals USA, Inc.)
The FDA approved a supplemental application for Buspirone hydrochloride (BuSpar) from Teva Pharmaceuticals USA, Inc., updating the product's…
-
CLINICAL_TRIALS trial_result · 2015-04-21Clinical Trial Update: A Clinical Trial to Study the Effects of Sensoril® for Patients With Generalized Anxiety Disorder [Phase 2]
This clinical trial update reports completion of a Phase 2 study evaluating Sensoril for generalized anxiety disorder.
-
CLINICAL_TRIALS trial_result · 2015-04-17Clinical Trial Update: Cognitive Behavioral Therapy for Anxiety Disorders in Adolescents With Autism [NA]
A completed clinical trial evaluated cognitive behavioral therapy for anxiety disorders in adolescents with autism, with results posted in 2…
-
FDA approval · 2015-04-16FDA Approved: ESCITALOPRAM — Supplemental Application (Accord Healthcare Inc.)
The FDA approved Accord Healthcare's supplemental application for a generic escitalopram product.
-
CLINICAL_TRIALS trial_result · 2015-04-13Clinical Trial Update: Acamprosate in Alcoholics With Comorbid Anxiety or Depression [Phase 4]
Phase 4 study evaluating acamprosate in individuals with alcohol use disorder and coexisting anxiety or depressive disorders; results have b…
-
CLINICAL_TRIALS trial_result · 2015-04-01Clinical Trial Update: Psychotherapy of Generalized Anxiety Disorder [Phase 3]
Phase 3 trial evaluating psychotherapy for generalized anxiety disorder has completed.
-
CLINICAL_TRIALS trial_result · 2015-03-06Clinical Trial Update: Open-Label Pilot Study to Examine the Value of Substituting Quetiapine for Benzodiazepines [Phase 4]
Open-label Phase 4 pilot trial evaluating substituting quetiapine for benzodiazepines in major depressive disorder and generalized anxiety d…
-
CLINICAL_TRIALS withdrawal · 2015-03-05Clinical Trial Update: A Phase 1 Study To Estimate The Effects Of PD 0332334 On Lithium Pharmacokinetics In Healthy Subjects [Phase 1]
Phase 1 study to estimate the effect of PD 0332334 on lithium pharmacokinetics in healthy subjects has been withdrawn.
-
FDA approval · 2014-12-30FDA Approved: BUSPIRONE HYDROCHLORIDE — Original Application (Accord Healthcare Inc.)
FDA approved an original ANDA for buspirone hydrochloride from Accord Healthcare Inc., enabling generic competition for this anxiety medicat…